Australia markets closed

Fennec Pharmaceuticals Inc. (FENC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
9.18+0.04 (+0.44%)
At close: 04:00PM EDT
9.18 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
21,252
21,252
1,535
0
170
Cost of revenue
1,259
1,259
86
0
-
Gross profit
19,993
19,993
1,449
0
-
Operating expenses
Research development
56
56
3,531
4,981
5,105
Selling general and administrative
32,708
32,708
20,507
12,242
12,950
Total operating expenses
33,051
33,051
24,187
17,223
18,055
Operating income or loss
-13,058
-13,058
-22,738
-17,223
-17,885
Interest expense
3,394
3,394
978
126
9
Total other income/expenses net
-34
-34
-193
-35
100
Income before tax
-16,045
-16,045
-23,714
-17,346
-18,109
Income from continuing operations
-16,045
-16,045
-23,714
-17,346
-18,109
Net income
-16,045
-16,045
-23,714
-17,346
-18,109
Net income available to common shareholders
-16,045
-16,045
-23,714
-17,346
-18,109
Basic EPS
-0.75
-0.60
-0.90
-0.67
-0.76
Diluted EPS
-0.75
-0.60
-0.90
-0.67
-0.76
Basic average shares
26,589
26,574
26,275
26,006
23,704
Diluted average shares
26,589
26,574
26,275
26,006
23,704